Eurobio Scientific signe un accord définitif en vue de l'acquisition de la division « Lab Products » de CareDx dédiée à la transplantation
Eurobio Scientific→CareDx Lab Products division
Apr 16, 2026

Channel-specific outreach playbooks for deal origination.
Comparison posts, methodology, and analysis from the Tentt team.
Monthly market reports on M&A and private equity activity.
Free calculators for M&A, lending, and deal analysis.
Origination in the Age of AI.
A strategic buyer has acquired a medical devices business in Alpharetta, Georgia, for $1.3B. The target develops and manufactures medical devices used in healthcare settings, supporting clinical workflows and patient care. The acquisition expands the buyer’s healthcare M&A footprint in GA acquisitions and strengthens its portfolio in the medical devices sub-sector. The deal is announced and valued at over $100M, reflecting a platform-style expansion by a strategic acquirer rather than a small add-on. Healthcare deals GA are driven by product breadth, manufacturing scale, and the ability to accelerate growth across medical device categories.
Filed under
Source
Read full article on pressreader.comvia GN - medical device equipment acquired · April 15, 2026
Powered by Tentt
Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.
Eurobio Scientific→CareDx Lab Products division
Apr 16, 2026
Quvara Medical→Becton Dickinson
Apr 15, 2026
Parkview Health→Witham Health Services
Apr 15, 2026
Surgery Partners→Preferred Vascular Group
Apr 15, 2026
Sectra→Oxipit
Apr 15, 2026